Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX) announced that its Board declared a quarterly cash dividend of $0.80 per share. The dividend is payable on January 28, 2026 to shareholders of record as of January 13, 2026. This provides a scheduled cash return to common shareholders and sets the key dates for eligibility and payment.
Quest Diagnostics (NYSE: DGX) ha annunciato che il suo Consiglio ha dichiarato un dividendo trimestrale in contanti di $0.80 per azione. Il dividendo è pagabile il 28 gennaio 2026 agli azionisti registrati al 13 gennaio 2026. Questo offre un ritorno in contanti pianificato agli azionisti comuni e stabilisce le date chiave per l'eligibilità e il pagamento.
Quest Diagnostics (NYSE: DGX) anunció que su Junta directiva declaró un dividendo trimestral en efectivo de $0.80 por acción. El dividendo se pagará el 28 de enero de 2026 a los accionistas registrados al 13 de enero de 2026. Esto proporciona un retorno de efectivo programado para los accionistas comunes y establece las fechas clave de elegibilidad y pago.
Quest Diagnostics (NYSE: DGX)는 이사회가 주당 0.80달러의 분기 현금 배당을 선언했다고 발표했습니다. 배당금은 2026년 1월 28일에 지급되며, 2026년 1월 13일 기준 주주에게 해당합니다. 이는 보통주 주주에게 예정된 현금 반환을 제공하고 자격 및 지급에 대한 주요 날짜를 설정합니다.
Quest Diagnostics (NYSE: DGX) a annoncé que son conseil d'administration a déclaré un dividende trimestriel en espèces de 0,80 $ par action. Le dividende sera payable le 28 janvier 2026 aux actionnaires inscrits au 13 janvier 2026. Cela fournit un retour en espèces programmé aux actionnaires ordinaires et fixe les dates clés d'admissibilité et de paiement.
Quest Diagnostics (NYSE: DGX) gab bekannt, dass der Vorstand eine vierteljährliche Bardividende in Höhe von $0,80 pro Aktie beschlossen hat. Die Dividende wird am 28. Januar 2026 an registrierte Aktionäre zum Stichtag 13. Januar 2026 gezahlt. Dies bietet eine geplante Barauszahlung an Stammaktionäre und legt die wichtigsten Termine für Anspruchsberechtigung und Zahlung fest.
Quest Diagnostics (NYSE: DGX) أعلنت أن مجلس إدارتها قرر توزيع أرباح نقدية ربع سنوية قدرها $0.80 للسهم. ستُدفع الأرباح في 28 يناير 2026 للمساهمين المسجلين حتى 13 يناير 2026. وهذا يوفر عائداً نقدياً مجدولاً للمساهمين العاديين ويضع التواريخ الرئيسية للأهلية والدفع.
- $0.80 per share quarterly dividend declared
- Dividend payable Jan 28, 2026
- Record date set as Jan 13, 2026 for eligibility
- Declared dividend creates a near-term cash outflow of $0.80 per share
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302612105.html
SOURCE Quest Diagnostics
FAQ
How much is Quest Diagnostics (DGX) paying per share for the quarterly dividend declared Nov 11, 2025?
When will Quest Diagnostics (DGX) pay the declared $0.80 dividend?
What is the record date to qualify for Quest Diagnostics (DGX) Jan 28, 2026 dividend?
If I buy DGX stock after January 13, 2026, will I receive the January 28, 2026 dividend?
Does the Quest Diagnostics (DGX) announcement change its dividend amount or schedule beyond Jan 28, 2026?
